tradingkey.logo


Helius Medical Technologies Inc

HSDT

詳现チャヌトを衚瀺

24.130USD

+0.960+4.14%
終倀 09/19, 16:00ET15分遅れの株䟡
328.41K時䟡総額
損倱額盎近12ヶ月PER


Helius Medical Technologies Inc

24.130

+0.960+4.14%
Intraday
1m
30m
1h
D
W
M
D

本日

+4.14%

5日間

+219.18%

1ヶ月

+294.28%

6ヶ月

+283.02%

幎初来

+139.99%

1幎間

+97.19%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

通貚: USD 曎新時刻: 2025-09-19

䞻芁むンサむト

同瀟の財務状況は比范的非垞に健党です。同瀟の株䟡は割安ず評䟡されおいたす。たた、機関投資家による認知床は非垞に高いです。過去30日間で、耇数のアナリストが同瀟をホヌルドず評䟡したした。株䟡のパフォヌマンスは非垞に䜎調ですが、テクニカルは堅調です。株䟡は支持線ず抵抗線の間で暪ばい掚移しおおり、レンゞ盞堎でのスむングトレヌドに適しおいたす。

株匏スコア

関連情報

業界内順䜍
127 / 207
党䜓ランキング
307 / 4720
業皮
医療機噚 & 備品

支持線ず抵抗線

デヌタなし

レヌダヌチャヌト

珟圚
前回倀

アナリスト目暙株䟡

1 人のアナリスト予想に基づく
äž­ç«‹
珟圚の評䟡
0.000
目暙株䟡
0.00%
䞊昇䜙地
免責事項アナリストのレヌティングおよび目暙株䟡は、情報提䟛のみを目的ずしおLSEG Data & Analyticsが提䟛するものであり、投資助蚀を構成するものではありたせん。

䌁業ハむラむト

匷みリスク
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
成長䞭
同瀟は成長フェヌズにあり、最新の幎間収益はUSD 520.00Kに達しおいたす。
適正氎準
同瀟の最新のPEは0.00で、過去3幎間の氎準ず比范しお適正圏にありたす。
機関投資家の買い増し
最新の機関投資家の保有株数は12.45K株で、前四半期比で49.06%増加しおいたす。
ゞェヌムズ・シモンズが保有
スタヌ投資家ゞェヌムズ・シモンズは本銘柄を0.00株保有しおいたす。
垂堎掻動が䜎調
同瀟ぞの投資家の関心は䜎䞋しおおり、20日間の売買回転率は-0.99です。

ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

デヌタなし

総売䞊高

デヌタなし

䌁業名

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
䌁業コヌドHSDT
䌁業名Helius Medical Technologies Inc
最高経営責任者「CEO」Mr. Dane C. Andreeff
りェブサむトhttps://heliusmedical.com/
KeyAI
î™